EGFR and neoplasm: Following IHC confirmation of DCBLD1 overexpression in two cases (Case 1: EGFR WT; Case 2: EGFR Mut, exon 19 deletion; Figure S7A), tumor tissues were used to establish both PDO and PDX models.